Oral tolerance is defined as a state of systemic hyporesponsiveness to an antigen that has been previously administered by the oral route. Many factors affect oral tolerance induction; some of them related to antigen, and some related to the animal. The age of the animal is one of the most important factors that affect oral tolerance as ageing brings many alterations in immune responses. Herein, we demonstrated that both the oral tolerance and pattern of immune reactivity triggered in early life were kept up to 15 months regarding the magnitude of antibody production, cell proliferation and cytokine profile when compared to immune responses induced in old mice. Therefore, our results corroborate with a promising proposal for prevaccination during childhood and young age, and a booster in older age, to make sure that the primary immunization in early life is not lost in aged individuals.
Introduction
Oral tolerance is defined as a state of systemic hyporesponsiveness to an antigen that has been previously administered by the oral route [1] [2] [3] [4] [5] [6] . Many factors can affect oral tolerance induction; some related to the antigen such as dose, nature, feeding regimen as well as the frequency and interval between feeding [7, 8] ; others related to the animal as microbiota, genetic background and immunological profile and age at the first contact with antigen [7, [9] [10] [11] [12] [13] [14] [15] . Mice become less susceptible to oral tolerance induction with 24 weeks of age and refractory with 70 weeks of age.
Indeed, ageing is associated with a decline in cellmediated immunity and increase in the morbidity/mortality from pneumonia caused by influenza infection [16, 17] . Immunization of old animals also results in poor immune responses [12, 13] .
Ageing is characterized by many alterations in the immune system [12, 13, 18, 19] . Our group has previously reported that ageing does not affect oral tolerance induction but its maintenance [7] . According to some authors, oral tolerance is sustained for a short period of 21 days to 3 months [12, 20] . By contrast, previous studies from our laboratory showed that although oral tolerance induction is affected by ageing, the suppression can be maintained for a period as long as 15 months after its induction by feeding [21] . In this study, we demonstrated that oral tolerance as well as the pattern of immune reactivity induced in young mice could be maintained for a lifetime period (up to 15 months) depending on the age and adjuvant used for the first immunization.
Materials and Methods
Animals. Female (C57BL:6 X DBA:2J)F1 abbreviated (B6D2F1) mice (2-18 months old) were obtained from CEBIO (Centro de Bioterismo/UFMG, Brazil) and maintained at room temperature in our conventional experimental animal facility throughout the experiments. Animals had free access to tap water and food throughout the experiments according to ethical guidelines of our institution. All animal procedures were approved by the local ethical committee for animal research (CETEA-UFMG, Brazil).
Antigen and adjuvant. Crystallized hen's egg albumin (OVA, grade III or V, Sigma, St. Louis, MO, USA) was used as antigen. Aluminium hydroxide [Al(OH) 3 ] and complete Freund adjuvant (CFA) -SIGMA Chemical Co., St. Louis, Mo, USA, were used as adjuvant.
Oral treatment and immunization. Eight-week-old mice were orally treated with OVA (tolerant group) or saline (immune group) and intraperitoneally (i.p.) immunized 7 days afterwards with OVA+Al(OH) 3 (tolerant and immune groups) or saline + Al(OH) 3 (control group). After 14 days, a booster was given with 10 lg OVA in saline to evaluate whether oral tolerance as well as immune reactivity was preserved in old mice which had previous contact with antigen when young. A control group was orally treated with saline and injected only with Al(OH) 3 when young and immunized with OVA when aged (70 weeks). After 15 months, three additional intraperitoneal immunizations were given: the first with OVA, the second with OVA+Al(OH) 3 and the third with OVA again. Alternatively, animals were immunized subcutaneous (s.c.) with 100 lg OVA emulsified in CFA (1:1).
Analysis of Ig isotypes by ELISA. Levels of OVA-specific immunoglobulins and specific IgM/IgG1/IgG2a/IgG2b/ IgG3/IgA were determined by ELISA. 96-well plates were coated with 2 lg/well OVA or 0.1 lg goat anti-mouse UNLB antibody, in coating buffer pH 9.8 overnight. Wells were washed and blocked with 200 ll of PBS containing 0.25% casein for 1 h at room temperature. Serum were added to the plate and incubated for 1 h at room temperature, plates were washed and then peroxidaseconjugated streptavidin goat anti-mouse or rat anti-goat (Southern Biotechnology) 1:150,000 was added, and plates were incubated for 1 h at 37°C. Reaction was developed at room temperature with 100 ll/well of orthophenylenediamine (1 mg/ml), 0.04% H 2 O 2 substrate in sodium citrate buffer. Reaction was interrupted by the addition of 20 ll/ well of 2N H 2 SO 4 . Absorbance was measured at 490 nm by an ELISA reader (Model 450 Microplate Reader; Bio-Rad, Houston, TX, USA).
Cell preparations and cytokine assays. Spleen and inguinal lymph nodes were removed and cell suspensions prepared and centrifuged. Cells isolated from spleen (erythrocyte depleted through cell lyses) and inguinal lymph nodes were cultured, at 1 9 10 6 cells/well in 96-well plates) in complete RPMI with or without 1 mg/ml grade V OVA. Supernatants were collected after 72 h to measure IL-4 and IFN-c. Plates were coated with purified monoclonal antibodies overnight, 4°C. In the following day, wells were washed and supernatants were added and left overnight at 4°C. In the third day, biotinylated monoclonal antibodies were added and left for 1 h at room temperature. Reaction was developed at room temperature with 100 ll/well of orthophenylenediamine (1 mg/ml), 0.04% H 2 O 2 substrate in sodium citrate buffer. Reaction was interrupted by the addition of 20 ll/well of 2N H 2 SO 4 . Absorbance was measured at 490 nm by an ELISA reader (Model 450 Microplate Reader; Bio-Rad).
Measurement of systemic delayed-type hypersensitivity (DTH). Twenty-eight days after immunization, old mice were challenged in the right and left hind footpad with 40 ll of 2% OVA aggregated by denaturation (600 lg OVA/ mouse). Using a caliper rule, foot thickness was measured before and after challenge (24, 48, 72 h) . The difference between these measurements was considered an index of footpad swelling and severity of DTH. Paws were removed for histological analyses after 72 h of last challenge and fixed in buffered formalin and were further dehydrated in alcohol solutions using a tissue processor. Paws were included in paraffin and 4-lm transverses sections obtained by Spencer microtome. Tissues were stained with eosin and haematoxylin and morphologic profile determined using an Olympus microscopic.
Lymphocyte proliferation assay. Mice were either orally treated and immunized (tolerant group) or only immunized (immune group). A group of animals that received only saline plus Al(OH) 3 without the antigen (OVA) when young (control group) was used. At 70 weeks of age, all mice were subcutaneously immunized with OVA emulsified in CFA on the tail. 10 days afterwards, spleen and inguinal lymph nodes were removed for cell suspension. Briefly, 1 9 10 6 cells/well were incubated at 37°C, 5% of CO 2 for 24, 40 or 72 h with 100 ll/well of OVA solution (10 mg/ml) or medium. After 72 h, 25 ll of tritiated thymidine [metil-
3 H] (20 lCi/ml/sp ativ/5 Ci/mmol) was added and left for 18 h. Cells were aspirated by an automatic cell harvester after 6-8 h. Filters disc were placed in tubes containing non-aqueous scintillation fluid and beta radioactivity. Results were expressed as stimulation
Statistical analysis. Results were expressed as mean AE SEM and analysed using GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, USA). Comparison between two groups was performed using Student's t test, and multiple comparisons were performed using ANOVA and Tukey post hoc test. Statistical significance was set at P < 0.05.
Results
Oral tolerance and susceptibility to immunization were preserved up to 15 months The results showed that oral tolerance was maintained in aged mice, even after a third booster with antigen, when production of anti-OVA antibodies was evaluated ( Fig. 1A-D) . Mice from the immune group showed high specific antibody levels, especially after the booster with OVA in adjuvant ( Fig. 1A-D) . The isotypic pattern of serum anti-OVA antibodies in aged mice, that were tolerized and immunized when young, was also tested (Fig. 1E-G) . After the third challenge with OVA, mice from control group still showed low antibody titres and a small increase in IgM levels. Although mice from immune and tolerant groups showed differences in isotype patterns of specific antibodies, there was a predominance of IgG1 in mice from both groups.
Proliferative activity of T cells in spleen and inguinal lymph nodes was conserved in aged mice that had contact with antigen when young Our results show that cells from spleen and inguinal nodes of aged control mice had a reduced proliferative ability when compared to immune mice that showed a higher proliferative index (Fig. 1H, I ). Evaluation of oral tolerance showed a reduction in proliferative index in tolerant mice compared to immune group (Fig. 1H, I ). Production of IL-2 by spleen cells cultured with antigen was also analysed (Fig. 1J) . T lymphocytes from control group challenged only when older secreted low amounts of IL-2, unlike the cells of older animals previously treated (tolerant and immune) that were capable to produce higher levels of IL-2. This result is consistent with the proliferative activity of these animals, as IL-2 is involved in T cell proliferation.
Adjuvant used for the first immunization determined the pattern of lifelong immune reactivity
Mice were orally treated as described in Materials and Methods. Fifteen months later, animals were s.c. immunized with OVA+CFA in the base of the tail. The cellular response in control group 24 h after booster was higher than that in immune and tolerant mice ( Fig. 2A) . Nonetheless, immune reactivity in mice in which oral tolerance was induced when young was lower than that found in the immune group (Fig. 2A) . The cellular response remained high up to 72 h after booster with OVA denatured +CFA in the control group (Fig. 2 A-C) , suggesting the development of a type IV hypersensitivity (DTH). By contrast, in mice that were immunized with OVA+Al(OH) 3 (Fig. 2B, C) , Figure 1 Total anti-OVA, isotype pattern anti-OVA antibodies and specific cell proliferation ability in aged mice orally treated and immunized as young. Eight-week-old mice were orally treated by gavage with 20 mg of OVA (tolerant group -T) or saline (immune control group -I) and i.p. immunized 7 days afterwards with 100 lg of OVA+ 3 mg of Al(OH) 3 . A booster with OVA was given 14 days afterwards. Mice that were immunized i.p. only with Al(OH) 3 were used as control (control group -C). At age of 70 weeks, blood from all groups was collected (A), afterwards an i.p. booster with 10 lg of OVA was given (B). After 14 days, a second challenge with 10 lg OVA +Al(OH) 3 was given (C) and 21 days afterwards mice received another booster with 10 lg of OVA (D). Blood was collect after each challenge. OVA-specific isotype antibody from immune (E), tolerant (F) and control (G) mice, after the last challenge with OVA, was evaluated. OVA-specific total and isotype antibodies were measured by capture ELISA. Sixty-two weeks after first treatment, at the age of 70 weeks, mice were challenged with OVA+CFA 1:1 (100 lg/mice) in the base of the tail. Ten days afterwards, cells from spleen (H) and inguinal lymph nodes (I) were isolated and stimulated in vitro with OVA (10 mg/ml). Cell suspensions from spleen were cultured with 500 lg/ml of OVA for IL-2 measurement by ELISA (J). Bars represent the mean AE SD of 5 mice per group (*P < 0.05).
Ó ............................................................................................................................................................... suggesting that these animals developed the late phase of type I hypersensitivity. The pattern of the cellular infiltrates was examined in histological sections of hind paws. Control mice showed an infiltrate of mononuclear cells, lymphocytes and macrophages, keeping this cellular pattern up to 72 h induced by immunization with OVA + CFA (Fig. 2D) . On the other hand, in tolerant (Fig. 2E ) and immune mice (Fig. 2F) that received a previous treatment with antigen adsorbed in another adjuvant (Al (OH) 3 ) when young, the cellular infiltrated was predominantly composed by eosinophils. The higher proportion of eosinophils observed in immune mice (Fig. 2F ) when compared to tolerant mice indicates a decrease in cellular response in the latter group.
Old mice maintained the immunoglobulin and cytokine profiles triggered by treatment at early age
We analysed anti-OVA and IgE immunoglobulin levels. Results showed a significant difference in anti-OVA antibody levels between tolerant ant immune groups (Fig. 2G) . Antibody production in control mice was lower than that in immune group, despite the higher cellular reaction, suggesting that the type of reaction induced in these mice was not dependent on antibodies, contrasting to immune group which showed high levels of total immunoglobulin (Fig. 2G) . Although it seems that immune mice produced higher level of anti-OVA serum IgE, when compared with control and tolerant group, there was no significant difference between the groups (Fig. 2H) . We next evaluated IL-4 and INF-gamma cytokine production in spleen and found that control mice challenged when aged were able to secrete high levels of INF-gamma but not IL-4 (Fig. 2I, J) . On the other hand, tolerant and immune mice produced higher amounts of IL-4 but low levels of INF-gamma (Fig. 2I) .
Discussion
The goal of the present work was to study oral tolerance maintenance evaluating aspects of immune responses that are suppressed during this phenomenon. We also aimed to investigate whether, along with oral tolerance, immune reactivity was preserved in old mice that had previous contact with antigen when young. Figure 2 Delayed-type hypersensitivity reaction (DTH), antibody and cytokine profile in aged mice orally treated and immunized when young. Eightweek-old mice were orally treated by gavage with 20 mg of OVA (tolerant group -T) or saline (immune control group -I) and i.p. immunized 7 days afterwards with 100 lg of OVA+ 3 mg of Al(OH) 3 . A booster with OVA was given 14 days afterwards. Mice that were immunized i.p with Al(OH) 3 without OVA were used as control (control group -C). Sixty-two weeks after first treatment, at the aged of 70 weeks, mice were challenged in the right and left hind footpad with 40 ll of 2% OVA aggregated by denaturation (600 lg OVA/mouse) with OVA+CFA 1:1 (100 lg/mice). After 28 days, all groups were challenged s.c. in the right and left hind footpad with denatured OVA. Thickness measurement was made 24(A), 48(B) and 72 (C) hours afterwards. The histological analyses were performed 72 h after the last challenge of OVA. Histology from control, tolerant and immune mice is shown in figures D, E and F, respectively. Figures are increased 40 9 3.3. Serum was collected 72 h afterwards and total antibody anti-OVA (G) and total antibody IgE (H) were measured. Spleen was removed, and cell suspensions were cultured with complete 500 lg/ml of OVA for IL-4 (I) and INF-gamma (J) measurements by ELISA. Bars represent the mean AE SD of five mice per group (*P < 0.05).
We have previously shown through specific antibody evaluation that oral tolerance can persist for up to 15 months [21] . Considering that 2 years is the average lifespan of a mouse [22] and that mice were treated when they were 8 weeks old, 15 months is a lifetime period.
In this study, aged mice that were immunized only with adjuvant when young were used as a control group to test our hypothesis that the age at the first contact with antigen is critical for memory generated during tolerance and immunization. Our results demonstrated that oral tolerance was well preserved in mice up to 15 months after oral treatment, when specific antibodies were measured, even after three additional boosters with soluble OVA or OVA in adjuvant (Fig. 1A-D) . In addition, we showed that a previous i.p. contact with antigen and adjuvant at early age was able to sustain a high systemic immune response in aged mice when compared with control mice that were not exposed to antigen when young.
The isotype pattern of aged mice orally treated and immunized when young was similar to that of young animals with the predominance of IgG1 isotype (Fig. 1E-F) . These results are in agreement with other reports showing that high dose oral tolerance yields a suppressive effect in specific antibodies of all isotypes [23] . Interestingly, control group that were immunized when old showed low levels of IgM. Therefore, not only antibody levels but also the isotypic pattern of antibodies was maintained in sensitized mice. As isotype class switch is a T cell-dependent process, these data suggest that maintenance of immune responses was dependent on the action of cytokines secreted by T lymphocytes. These results suggest that aged mice, immunized when young, were able to keep an immune response pattern similar to that seen in young animals. Apparently, not only the capacity for immunization and tolerance persists throughout the animal's life but also its pattern of reactivity.
T cell was evaluated by proliferation assay. Spleen cells and inguinal lymph nodes from control mice (challenged with OVA only at old age) have low proliferative ability when stimulated with OVA suggesting refractivity of aged mice to further antigenic stimulation. However, immune mice showed higher proliferative ability than control and tolerant group demonstrating that a previous contact with antigen is able to keep immune activity pattern (Fig. 1H, I ). A continuous exposition of antigen is fundamental for oral tolerance maintenance. However, although those mice were immunized with OVA in an adjuvant [Al (OH) 3 ] which is thought to form 'depot' that slow antigen release [24] , it has never been demonstrated that antigen could persist in adjuvant-induced 'depot' for such a long time. One possibility would be that circuits of memory immune T cells, activated during oral tolerance and immunization processes, suffer expansion due to inflammatory action of antigen plus adjuvant helping their maintenance. Old animals treated with antigen when young present a pattern of immune response similar to that of the young animal, as OVA antigen could not be considered a new antigen, which prevented refractoriness to OVA.
Production of IL-2 by spleen cells was analysed (Fig. 1J ) and showed that old mice had, as expected, a defective proliferative response and IL-2 production. On the other hand, immune mice maintained their proliferative capacity while tolerant mice had it suppressed. IL-2 production was consistent with these results as IL-2 is involved in the cell proliferation process. This pattern of proliferative capacity maintained in immune and tolerant mice is also consistent with the hypothesis of a memory circuit kept in mice treated as young.
We further decided to investigate an in vivo DTH reaction to measure the Th1 response in these animals. Surprisingly, only control group were able to develop a DTH response to OVA in CFA presenting a high cellular reaction up to 72 h after challenge (Fig. 2C) . This reaction was higher in control group when compared to tolerant and immune groups. On the other hand, in the first 24 h, we could observe a higher reaction in immune mice when compared to tolerant counterparts. The distinct kinetic pattern of paw swelling measured suggested that a different immune reaction, possibly a late phase of type I hypersensitivity reaction, occurred in immune and tolerant groups. This type of reaction is typical of allergy, occurring 24 h after immunization with antigen in the presence of alum adjuvant, which induces a Th2 immune response. Indeed, we confirmed, by histological analysis of the inflammatory infiltrates, that immune and tolerant mice, that had previous contact with antigen, developed a type I late phase reaction with predominance of polymorphonuclear cells, especially eosinophils (Fig. 2E, F) . Tolerant mice showed a reduced cellular infiltrate compared with immune group, demonstrating that oral tolerance was still in place. At the same time, control group showed a typical delayed-type hypersensitivity reaction with an infiltrate of mononuclear cells (Fig. 2D) . Our results suggest that the pattern of reactivity induced in young mice can be maintained throughout life for that specific antigen (Fig. 2G, H) . Immunization with antigen in Al(OH) 3 induces a Th2-polarized immune response to OVA in young mice. Our results showed that this pattern was sustained in aged mice immunized when young, even when Th1-polarized adjuvant, such as CFA, was used with the same antigen in these mice. Indeed, cytokine analyses in the draining lymph nodes of immune and tolerant mice showed higher levels of IL-4 and lower IFN-gamma production demonstrating a typical Th2 profile, characteristic of type I hypersensitivity reaction as IL-4 is involved in IgE class switch [21] . On the other hand, cell culture of control mice showed a typical Th1 pattern with higher levels of IFN-gamma but no IL-4, characteristic of DTH (Fig. 2I,  J) . Cytokine secretion by lymphocytes and macrophages plays a fundamental role in DTH reaction as these mononuclear cells are preferentially recruited to the site of challenge [24, 25] . Therefore, these data suggest that not only tolerance ............................................................................................................................................................... but also immunization pattern induced in young mice can be maintained throughout life ageing.
Our results demonstrated that standard reactivity acquired in youth triggered immunological memory circuits that can be recalled much later in life, once the same antigen was used in the immunizations in the different stages. Therefore, they support the hypothesis that regular vaccination schedules during youth may have a critical impact in the success of booster vaccination in the elderly [26] [27] [28] [29] . Data in the literature demonstrate a poor protective effect of vaccination in older individual as compared to children and young adults [30] [31] [32] [33] [34] [35] [36] [37] . This infectiveness of immunization is likely related to alterations in the immune system during ageing that includes functional disability of antigen presenting cells (APCs), reduction in na€ ıve T and B lymphocytes, as well as low ability of T cells to help B lymphocytes in the class switch isotype and antibody production. The result of all ageassociated changes is a reduced ability of the immune system to incorporate reactivity's to new antigens, impairing a successful immunization. Therefore, our work supports the proposal of prevaccination procedures during childhood and young age as an effective way to insure proper immunization of aged individuals submitted to vaccination. At the same time, it also shows that acquisition of specific tolerance to certain antigens could be successfully recalled at advanced age.
